WayFinder Ride Phase I Study
Public ClinicalTrials.gov record NCT07437651. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
WayFinder Ride Phase I Study Device Usability Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Phase I will culminate with a pilot study designed to evaluate the usability and accessibility of the WayFinder Ride prototype system to enable people with IDD to request an Uber or Lyft ride. Participants will rate both systems on factors of usability and accessibility. The number and types of errors and assistance needed using the prototype will be tracked to compare use of each of the applications. It is hypothesized that the participants with IDD will have significantly fewer errors and need less help when using the cognitively accessible WayFinder Ride interface than the Uber or Lyft interfaces. Additionally, it is hypothesized that WayFinder Ride will have significantly higher rating scores on usability and accessibility. Sixty-six people with IDD will participate in this Phase I study.
Study identification
- NCT ID
- NCT07437651
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- WayFinder Ride Phase I Prototype Device
- Lyft Rideshare App Device
- Uber Rideshare App Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2025
- Primary completion
- Dec 2, 2025
- Completion
- Dec 8, 2025
- Last update posted
- Feb 26, 2026
2025
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| REACH Collective, Temple University | Philadelphia | Pennsylvania | 19122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07437651, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2026 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07437651 live on ClinicalTrials.gov.